MT2015-12 : Phase 3 Randomized, Double-Blind, Placebo Co

Project: Research project

Project Details

Description

MT2015-12 : Phase 3 Randomized, Double-Blind, Placebo Controlled, Multicenter Study
StatusActive
Effective start/end date3/31/1512/31/23

Funding

  • Celgene Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.